.png)
£154M
The financing round was backed by existing major investors and new participant Trinity Capital.
CS
CMR Surgical
CMR Surgical manufactures the Versius system for robotic minimal access surgery.
Cambridge, UK—Founded 2014
£907MTotal raised
CMR Surgical develops the Versius Surgical Robotic System, a widely adopted soft tissue surgical robot used in tens of thousands of procedures worldwide. Headquartered in Cambridge, the company works to make robotic minimal access surgery more accessible.
Categories
Team
EL
Erik Langaker
Chairman
MF
Martin Frost
Chief Executive Officer
PV
Per Vegard Nerseth
Chief Executive Officer
Per brings robotics board and executive experience, having previously led CMR Surgical as chief executive officer. He currently serves as a senior advisor at EQT Group alongside board and nominee roles across multiple organisations.
LinkedInSB
Supratim Bose
Chief Executive Officer
Supratim brings extensive medical technology leadership experience, having previously served as chief executive officer of CMR Surgical and held senior executive roles at Boston Scientific, ConvaTec, and Johnson & Johnson. He currently serves as vice chairman of the board at CMR Surgical and founder and chief executive officer of Bose Management Consulting.
LinkedIn
Andre Nel
CFO
Andre brings financial leadership experience across healthcare, medical technology, and life sciences companies. He currently serves as chief financial officer at CMR Surgical, following previous CFO roles at LUMICKS, Dante Labs, and Illumina.
LinkedIn
Massimiliano Colella
Chief Executive Officer
Massimiliano brings healthcare leadership experience from executive roles at CMR Surgical, Evercare Group, and Smith & Nephew.
LinkedInDM
Dan Moore
Non-Executive Chairman
Investors
- £154M
- £133M
- £425M
- £195M
Funding history
£133M
The upsized funding round was led by existing backers including Ally Bridge Group and Lightrock.
£425M
The funding round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group to support international expansion and technological development.
£195M
The record European medtech financing was backed by new US investors and existing partners including LGT and Cambridge Innovation Capital.